Carlos Hoyo-Vadillo
Overview
Explore the profile of Carlos Hoyo-Vadillo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Perez Gutierrez R, Hoyo-Vadillo C
Pharmacogn Mag
. 2017 Aug;
13(Suppl 2):S174-S178.
PMID: 28808377
Background: Defense and protection to multiple harmful stimuli are the inflammation, when is self-amplified and uncontrolled is the basis of the pathogenesis of a wide variety of inflammatory illness. The...
12.
Arrieta-Cortes R, Farias P, Hoyo-Vadillo C, Kleiche-Dray M
Regul Toxicol Pharmacol
. 2016 Nov;
83:66-80.
PMID: 27871870
Methods: As a guiding axis, we used the IARC process for developing monographs of carcinogenic risks. We used the SIGN guides for evaluating the quality of studies in human populations;...
13.
Ulloa-Martinez M, Burguete-Garcia A, Murugesan S, Hoyo-Vadillo C, Cruz-Lopez M, Garcia-Mena J
Arch Med Sci
. 2016 Oct;
12(5):968-976.
PMID: 27695486
Introduction: Obesity is a chronic, complex, and multifactorial disease, characterized by excess body fat. Diverse studies of the human genome have led to the identification of susceptibility genes that contribute...
14.
Kalyanasundar B, Solorio J, Perez C, Hoyo-Vadillo C, Simon S, Gutierrez R
Appetite
. 2016 Feb;
100:152-61.
PMID: 26867698
Obesity is a public health problem caused by excessive consumption of high caloric diets and/or lack of physical activity. Although treatments for obesity include low caloric diets and exercise programs,...
15.
Escobar Y, Venturelli C, Hoyo-Vadillo C
Curr Ther Res Clin Exp
. 2014 Mar;
66(3):238-46.
PMID: 24672127
Background: The pharmacokinetic properties of pravastatin, particularlyAUC and Cmax, are variable by population. A description of the pharmacokinetic properties of pravastatin in Mexican mestizos was not found in a search...
16.
Castelan-Martinez O, Hoyo-Vadillo C, Sandoval-Garcia E, Sandoval-Ramirez L, Gonzalez-Ibarra M, Solano-Solano G, et al.
Gene
. 2013 Apr;
523(2):167-72.
PMID: 23587916
Allele frequency differences of functional CYP2C9 polymorphisms are responsible for some of the variation in drug response observed in human populations. The most relevant CYP2C9 functional variants are CYP2C9*2 (rs1799853)...
17.
Perez Gutierrez R, Gonzalez A, Hoyo-Vadillo C
Mini Rev Med Chem
. 2013 Jan;
13(2):163-93.
PMID: 23279257
Objective: Piper has been used for long timelike condiment and food, but also in traditional medicine around of the world. This work resumes the available and up to date work...
18.
Pozos-Guillen A, Aguirre-Banuelos P, Arellano-Guerrero A, Castaneda-Hernandez G, Hoyo-Vadillo C, Perez-Urizar J
Life Sci
. 2006 Aug;
79(24):2275-82.
PMID: 16934842
Tramadol is an atypical opioid with a complex mechanism of action including a synergistic interaction between the parent drug and an active metabolite. The local action of the parent drug...
19.
Garibay-Orijel C, Hoyo-Vadillo C, Ponce-Noyola T, Garcia-Mena J, Poggi-Varaldo H
Biotechnol Bioeng
. 2006 Apr;
94(5):949-60.
PMID: 16586508
A fluidized bed bioreactor (FBBR) was operated for more than 1000 days under two regimes, Methanogenic (M) and Methanogenic-Aerobic (M-A), to remove 2,4,6-trichlorophenol (TCP) and phenol (Phe) from a synthetic...
20.
Hoyo-Vadillo C, Venturelli C, Gonzalez H, Romero E, Cervantes R, Mata N, et al.
Proc West Pharmacol Soc
. 2006 Jan;
48:108-9.
PMID: 16416673
Proton pump inhibitors (PPIs) have been used recently for gastrointestinal esophageal reflux disease (GERD) in children older than one year with good results. However, the pharmacokinetics of PPIs have not...